These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
429 related articles for article (PubMed ID: 11883957)
1. Deficiency of alpha-dystroglycan in muscle-eye-brain disease. Kano H; Kobayashi K; Herrmann R; Tachikawa M; Manya H; Nishino I; Nonaka I; Straub V; Talim B; Voit T; Topaloglu H; Endo T; Yoshikawa H; Toda T Biochem Biophys Res Commun; 2002 Mar; 291(5):1283-6. PubMed ID: 11883957 [TBL] [Abstract][Full Text] [Related]
2. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029 [TBL] [Abstract][Full Text] [Related]
3. Dystroglycan glycosylation and its role in matrix binding in skeletal muscle. Martin PT Glycobiology; 2003 Aug; 13(8):55R-66R. PubMed ID: 12736199 [TBL] [Abstract][Full Text] [Related]
4. [Dystroglycan linkage and muscular dystrophy]. Shimizu T Rinsho Shinkeigaku; 2002 Nov; 42(11):1091-4. PubMed ID: 12784674 [TBL] [Abstract][Full Text] [Related]
5. Expression and localization of fukutin, POMGnT1, and POMT1 in the central nervous system: consideration for functions of fukutin. Yamamoto T; Kato Y; Kawaguchi M; Shibata N; Kobayashi M Med Electron Microsc; 2004 Dec; 37(4):200-7. PubMed ID: 15614444 [TBL] [Abstract][Full Text] [Related]
6. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Michele DE; Barresi R; Kanagawa M; Saito F; Cohn RD; Satz JS; Dollar J; Nishino I; Kelley RI; Somer H; Straub V; Mathews KD; Moore SA; Campbell KP Nature; 2002 Jul; 418(6896):417-22. PubMed ID: 12140558 [TBL] [Abstract][Full Text] [Related]
7. [Alpha-dystroglycanopathy (FCMD, MEB, etc): abnormal glycosylation and muscular dystrophy]. Toda T Rinsho Shinkeigaku; 2005 Nov; 45(11):932-4. PubMed ID: 16447766 [TBL] [Abstract][Full Text] [Related]
8. Muscular dystrophy associated with beta-Dystroglycan deficiency. Salih MA; Sunada Y; Al-Nasser M; Ozo CO; Al-Turaiki MH; Akbar M; Campbell KP Ann Neurol; 1996 Dec; 40(6):925-8. PubMed ID: 9007100 [TBL] [Abstract][Full Text] [Related]
10. Glycosylation defects: a new mechanism for muscular dystrophy? Grewal PK; Hewitt JE Hum Mol Genet; 2003 Oct; 12 Spec No 2():R259-64. PubMed ID: 12925572 [TBL] [Abstract][Full Text] [Related]
11. Ultrastructural localization of adhalin, alpha-dystroglycan and merosin in normal and dystrophic muscle. Cullen MJ; Walsh J; Roberds SL; Campbell KP Neuropathol Appl Neurobiol; 1996 Feb; 22(1):30-7. PubMed ID: 8866780 [TBL] [Abstract][Full Text] [Related]
12. [Finding of O-mannosyl glycan in mammals and congenital muscular dystrophies due to glycosylation defects]. Endo T Yakugaku Zasshi; 2003 Oct; 123(10):825-35. PubMed ID: 14577328 [TBL] [Abstract][Full Text] [Related]
13. Hypoglycosylation of alpha-dystroglycan in patients with hereditary IBM due to GNE mutations. Huizing M; Rakocevic G; Sparks SE; Mamali I; Shatunov A; Goldfarb L; Krasnewich D; Gahl WA; Dalakas MC Mol Genet Metab; 2004 Mar; 81(3):196-202. PubMed ID: 14972325 [TBL] [Abstract][Full Text] [Related]
14. Congenital muscular dystrophy with glycosylation defects of alpha-dystroglycan in Japan. Matsumoto H; Hayashi YK; Kim DS; Ogawa M; Murakami T; Noguchi S; Nonaka I; Nakazawa T; Matsuo T; Futagami S; Campbell KP; Nishino I Neuromuscul Disord; 2005 May; 15(5):342-8. PubMed ID: 15833426 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of dystroglycan binding to laminin disrupts the PI3K/AKT pathway and survival signaling in muscle cells. Langenbach KJ; Rando TA Muscle Nerve; 2002 Nov; 26(5):644-53. PubMed ID: 12402286 [TBL] [Abstract][Full Text] [Related]
16. Enzymatic diagnostic test for Muscle-Eye-Brain type congenital muscular dystrophy using commercially available reagents. Zhang W; Vajsar J; Cao P; Breningstall G; Diesen C; Dobyns W; Herrmann R; Lehesjoki AE; Steinbrecher A; Talim B; Toda T; Topaloglu H; Voit T; Schachter H Clin Biochem; 2003 Jul; 36(5):339-44. PubMed ID: 12849864 [TBL] [Abstract][Full Text] [Related]
17. Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy. Hayashi YK; Ogawa M; Tagawa K; Noguchi S; Ishihara T; Nonaka I; Arahata K Neurology; 2001 Jul; 57(1):115-21. PubMed ID: 11445638 [TBL] [Abstract][Full Text] [Related]
18. Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycan. Kuwabara N; Manya H; Yamada T; Tateno H; Kanagawa M; Kobayashi K; Akasaka-Manya K; Hirose Y; Mizuno M; Ikeguchi M; Toda T; Hirabayashi J; Senda T; Endo T; Kato R Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9280-5. PubMed ID: 27493216 [TBL] [Abstract][Full Text] [Related]
19. Protein glycosylation in disease: new insights into the congenital muscular dystrophies. Martin-Rendon E; Blake DJ Trends Pharmacol Sci; 2003 Apr; 24(4):178-83. PubMed ID: 12707004 [TBL] [Abstract][Full Text] [Related]
20. Molecular interaction between fukutin and POMGnT1 in the glycosylation pathway of alpha-dystroglycan. Xiong H; Kobayashi K; Tachikawa M; Manya H; Takeda S; Chiyonobu T; Fujikake N; Wang F; Nishimoto A; Morris GE; Nagai Y; Kanagawa M; Endo T; Toda T Biochem Biophys Res Commun; 2006 Dec; 350(4):935-41. PubMed ID: 17034757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]